Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Much Will The Peptic Ulcer Market Be Worth By 2029?
The market value of peptic ulcer has seen continuous growth in the past few years. It is expected to increase from $4.1 billion in 2024 to $4.22 billion in 2025, with a compound annual growth rate (CAGR) of 3.0%. The factors leading to this growth during the historical period include a higher incidence of Helicobacter pylori infection, an increase in the usage of nonsteroidal anti-inflammatory drugs (NSAIDs), alterations in lifestyle and food habits, publicity drives and instructional programs, as well as a concentration on stress administration.
The market size of peptic ulcers is anticipated to experience consistent growth in the coming years. The market is projected to reach $4.89 billion in 2029, growing at a compound annual growth rate (CAGR) of 3.8%. This growth during the forecast period can be credited to the rise of new therapies and treatment methods, an uptick in the elderly population, the infiltration of precision medicine, health enhancement and preventive actions, and ongoing research and clinical trials. Notable trends during the forecast period encompass health solutions in the digital arena, improvements in treatment methods, a rising incidence of helicobacter pylori infection, the incorporation of diagnostic imaging technologies, and a surge in the usage of combined therapies.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13221&type=smp
What Market Forces Are Contributing To The Growth Of The Peptic Ulcer Market?
The rise in obesity cases is predicted to boost the peptic ulcer market’s expansion in the future. Obesity, a health issue marked by excessive body fat accumulation leading to a body mass index (BMI) of 30 or more, can be traced back to genetic, environmental, and lifestyle influences, including poor nutrition and inadequate physical exertion. The overproduction of stomach acid, weakening of the stomach’s protective mucosal layer, and peptic ulcer development are all outcomes of obesity. Additionally, carrying extra weight seems to induce gut inflammation, which can bring about peptic ulcers. For example, the Centers for Disease Control and Prevention, a US health agency, reported in September 2024 that from August 2021 to August 2023, adult obesity rates were at 40.3%, distributed as 39.2% in men and 41.3% in women. As a result, the escalating prevalence of obesity is fueling the peptic ulcer market’s growth.
Which Segments Define The Structure Of The Peptic Ulcer Market?
The peptic ulcermarket covered in this report is segmented –
1) By Disease Indication: Gastritis; Gastric Ulcer; Duodenal Ulcer; Gastroesophageal Reflux Disease (GERD)
2) By Drug Type: Proton Pump Inhibitors (PPI); H2 Antagonists; Antibiotics; Other Drugs
3) By Distribution Channel: Hospital Pharmacies; Private Clinics; Drug Store; Retail Pharmacies; E-Commerce
Subsegments:
1) By Gastritis: Acute Gastritis; Chronic Gastritis
2) By Gastric Ulcer: Acute Gastric Ulcer; Chronic Gastric Ulcer
3) By Duodenal Ulcer: Acute Duodenal Ulcer; Chronic Duodenal Ulcer
4) By Gastroesophageal Reflux Disease (GERD): Non-Erosive GERD; Erosive GERD
Which Long-Term Trends Will Play A Crucial Role In The Peptic Ulcer Market?
To maintain a competitive advantage, firms in the peptic ulcer market are focusing on creating innovative products and solutions and securing their approval from governmental bodies. Creating new drugs plays an essential role in dealing with and treating peptic ulcers as it helps manage symptoms, heal ulcers, prevent complications, and address the root cause of the issue. In April 2023, an India-based pharmaceutical company called Akard Drugs and Pharmaceutical Ltd. introduced its latest product, the Combikit, which merges Amoxicillin, Clarithromycin, and Esomeprazole. The Central Drugs Standard Control Organisation (CDSCO) has given its approval for the Combikit to be used for addressing duodenal ulcers associated with Helicobacter pylori (H. pylori) and for eliminating H. pylori in patients who have active or healed peptic ulcers. The therapy, which targets H. pylori, has proven to be effective in cutting down the chances of ulcers coming back, thus providing significant advantages to patients. In India, where H. pylori infection is common, it’s usually linked to gastritis and peptic ulcer formation.
Which Firms Are Making The Biggest Impact In The Peptic Ulcer Market?
Major companies operating in the peptic ulcer market report are Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., CSL Limited, Boehringer Ingelheim International GmbH, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Company, Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Zydus Lifesciences, Lupin Limited, Livzon Pharmaceutical Group Inc., Yuhan Corporation, Torrent Pharmaceuticals Ltd., Daewoong Pharmaceutical Co. Ltd., Ilyang Pharmaceutical Co, Jiangsu Carephar Pharmaceutical Co Ltd.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/peptic-ulcer-global-market-report
Which Region Is Forecasted To Lead The Peptic Ulcer Market In The Coming Years?
North America was the largest region in the peptic ulcer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptic ulcer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=13221&type=smp
Browse Through More Reports Similar to the Global Peptic Ulcer Market 2025, By The Business Research Company
Diabetic Foot Ulcer Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/diabetic-foot-ulcer-global-market-report
Diabetic Foot Ulcer Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/diabetic-foot-ulcer-treatment-global-market-report
Ulcerative Colitis Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/ulcerative-colitis-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
